✦ LIBER ✦

Immunohistochemical analysis of Omi/HtrA2 expression in prostate cancer and benign prostatic hyperplasia

✍ Scribed by XIAO-YONG HU; YUE-MIN XU; XIAO CHUN CHEN; HAO PING; ZHAO-HUI CHEN; FU-QING ZENG

Book ID: 109343463
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 171 KB
Volume: 114
Category: Article
ISSN: 0365-5555
DOI: 10.1111/j.1600-0463.2006.apm_271.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunohistochemical analysis of Omi/HtrA

Immunohistochemical analysis of Omi/HtrA2 expression in prostate cancer and benign prostatic hyperplasia

✍ Hu Xiaoyong; Chen Xiaochun; Ping Hao; Chen Zhaohui; Zeng Fuqing; Lu Gongcheng 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 Chinese ⚖ 420 KB

Aromatization of androstenedione to estr

Aromatization of androstenedione to estrogen by benign prostatic hyperplasia, prostate cancer and expressed prostatic secretions

✍ Stone, N.N. ;Laudone, V.P. ;Fair, W.R. ;Fishman, J. 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 256 KB

Human prostatic tissue and expressed prostatic secretions (EPS) from patients with benign prostatic hyperplasia (BPH) and prostate cancer were incubated with (1 beta 3H) androstenedione. The extent of aromatization was determined by measuring the transfer of 3H from the 1 beta position into water. T

The expression of thrombospondin-1 in be

The expression of thrombospondin-1 in benign prostatic hyperplasia and prostatic intraepithelial neoplasia is decreased in prostate cancer

✍ C. Vallbo; W. Wang; J.-E. Damber 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 210 KB

Expression analysis and study of the KLK

Expression analysis and study of the KLK15 mRNA splice variants in prostate cancer and benign prostatic hyperplasia

✍ Konstantinos Mavridis; Margaritis Avgeris; Georgios Koutalellis; Konstantinos St 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 265 KB

31P NMR of phospholipid metabolites in p

31P NMR of phospholipid metabolites in prostate cancer and benign prostatic hyperplasia

✍ Richard A. Komoroski; John C. Holder; Alex A. Pappas; Alex E. Finkbeiner 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

## Abstract ^1^H MRSI in vivo is increasingly being used to diagnose prostate cancer noninvasively by measurement of the resonance from choline‐containing phospholipid metabolites. Although ^31^P NMR in vivo or in vitro is potentially an excellent method for probing the phospholipid metabolites pro

Leptin in relation to prostate cancer an

Leptin in relation to prostate cancer and benign prostatic hyperplasia

✍ Pagona Lagiou; Lisa B. Signorello; Dimitrios Trichopoulos; Anastasia Tzonou; Ant 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 44 KB 👁 2 views

The aim of our study was to determine whether leptin, a hormone implicated in both energy-balance and reproductive function, is involved in the etiology of prostate cancer or benign prostatic hyperplasia (BPH). We compared the serum leptin levels of 43 cases of incident prostate cancer, 41 patients